Fever and Leukocytosis Are Poor Predictors of Bacterial Coinfection in Patients With COVID-19 and Influenza Who Are Receiving Extracorporeal Membrane Oxygenation.

Luke B Jackson Michal J SobieszczykJames K AdenJoseph E Marcus

Published in: Open forum infectious diseases (2023)

In patients with influenza or COVID-19 who require ECMO, fever and leukocytosis were common indications for infectious workups, yet results were frequently negative. Despite their use in clinical practice, fever and leukocytosis are not reliable indicators of infection in patients who are hemodynamically stable and receiving ECMO.

Keyphrases

extracorporeal membrane oxygenation
acute respiratory distress syndrome
respiratory failure
end stage renal disease
clinical practice
newly diagnosed
chronic kidney disease
coronavirus disease
ejection fraction
sars cov
peritoneal dialysis
mechanical ventilation
respiratory syndrome coronavirus